Literature DB >> 33299142

SARS-CoV-2 antibody responses in patients with acute leukaemia.

J O'Nions1, L Muir2, J Zheng3, C Rees-Spear2, A Rosa4, C Roustan4, C Earl4, P Cherepanov4, R Gupta3,5, A Khwaja3,5, C Jolly2, L E McCoy6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33299142      PMCID： PMC7724438          DOI： 10.1038/s41375-020-01103-2

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.

Authors:  Nikolay Mayanskiy; Polina Luchkina; Natalia Fedorova; Yuri Lebedin; Natalia Ponomareva
Journal:  Leukemia       Date:  2021-05-18       Impact factor: 11.528

2.  Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.

Authors:  Aljawharah Alrubayyi; Ester Gea-Mallorquí; Emma Touizer; Dan Hameiri-Bowen; Jakub Kopycinski; Bethany Charlton; Natasha Fisher-Pearson; Luke Muir; Annachiara Rosa; Chloe Roustan; Christopher Earl; Peter Cherepanov; Pierre Pellegrino; Laura Waters; Fiona Burns; Sabine Kinloch; Tao Dong; Lucy Dorrell; Sarah Rowland-Jones; Laura E McCoy; Dimitra Peppa
Journal:  Res Sq       Date:  2021-03-17

3.  The effect of spike mutations on SARS-CoV-2 neutralization.

Authors:  Chloe Rees-Spear; Luke Muir; Sarah A Griffith; Judith Heaney; Yoann Aldon; Jonne L Snitselaar; Peter Thomas; Carl Graham; Jeffrey Seow; Nayung Lee; Annachiara Rosa; Chloe Roustan; Catherine F Houlihan; Rogier W Sanders; Ravindra K Gupta; Peter Cherepanov; Hans J Stauss; Eleni Nastouli; Katie J Doores; Marit J van Gils; Laura E McCoy
Journal:  Cell Rep       Date:  2021-03-06       Impact factor: 9.423

4.  Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection.

Authors:  Luke Muir; Aneesa Jaffer; Chloe Rees-Spear; Vignesh Gopalan; Fernando Y Chang; Raymond Fernando; Gintare Vaitkute; Chloe Roustan; Annachiara Rosa; Christopher Earl; Gayathri K Rajakaruna; Peter Cherepanov; Alan Salama; Laura E McCoy; Reza Motallebzadeh
Journal:  Kidney Int Rep       Date:  2021-04-28

5.  COVID-19 vaccines for patients with haematological conditions.

Authors:  Clare Sun; Christopher Pleyer; Adrian Wiestner
Journal:  Lancet Haematol       Date:  2021-03-31       Impact factor: 18.959

6.  Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2.

Authors:  Mariana O Diniz; Nathalie M Schmidt; Oliver E Amin; Aneesh Chandran; Emily Shaw; Leo Swadling; Corinna Pade; Joseph M Gibbons; Nina Le Bert; Anthony T Tan; Anna Jeffery-Smith; Cedric C S Tan; Christine Y L Tham; Stephanie Kucykowicz; Gloryanne Aidoo-Micah; Joshua Rosenheim; Jessica Davies; Marina Johnson; Melanie P Jensen; George Joy; Laura E McCoy; Ana M Valdes; Benjamin M Chain; David Goldblatt; Daniel M Altmann; Rosemary J Boyton; Charlotte Manisty; Thomas A Treibel; James C Moon; Lucy van Dorp; Francois Balloux; Áine McKnight; Mahdad Noursadeghi; Antonio Bertoletti; Mala K Maini
Journal:  Nature       Date:  2021-11-10       Impact factor: 69.504

7.  Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV.

Authors:  Aljawharah Alrubayyi; Ester Gea-Mallorquí; Emma Touizer; Dan Hameiri-Bowen; Jakub Kopycinski; Bethany Charlton; Natasha Fisher-Pearson; Luke Muir; Annachiara Rosa; Chloe Roustan; Christopher Earl; Peter Cherepanov; Pierre Pellegrino; Laura Waters; Fiona Burns; Sabine Kinloch; Tao Dong; Lucy Dorrell; Sarah Rowland-Jones; Laura E McCoy; Dimitra Peppa
Journal:  bioRxiv       Date:  2021-02-16

8.  Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort.

Authors:  Nishkantha Arulkumaran; Timothy Arthur Chandos Snow; Adarsh Kulkarni; David Brealey; Hannah Rickman; Chloe Rees-Spear; Moira J Spyer; Judith Heaney; Edmund Garr; Bryan Williams; Peter Cherepanov; George Kassiotis; Michael Lunn; Catherine Houlihan; Laura E McCoy; Eleni Nastouli; Mervyn Singer
Journal:  Crit Care Explor       Date:  2021-08-06

9.  Patterns of neutralizing humoral response to SARS-CoV-2 infection among hematologic malignancy patients reveal a robust immune response in anti-cancer therapy-naive patients.

Authors:  Cinzia Borgogna; Riccardo Bruna; Gloria Griffante; Licia Martuscelli; Marco De Andrea; Daniela Ferrante; Andrea Patriarca; Abdurraouf Mokhtar Mahmoud; Valentina Gaidano; Monia Marchetti; Davide Rapezzi; Michele Lai; Mauro Pistello; Marco Ladetto; Massimo Massaia; Gianluca Gaidano; Marisa Gariglio
Journal:  Blood Cancer J       Date:  2022-01-18       Impact factor: 11.037

10.  Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy.

Authors:  Wei Yee Chan; Emilie Sanchez; Selina J Chavda; Catherine S Y Lecat; Louise Ainley; Ke Xu; Brendan Wisniowski; Shameem Mahmood; Xenofon Papanikolaou; Charalampia Kyriakou; Jonathan Sive; Ashutosh Wechalekar; Rakesh Popat; Neil Rabin; Lydia Lee; Eleni Nastouli; Kwee L Yong
Journal:  Br J Haematol       Date:  2021-07-29       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.